Industry Urged To Use ICH Q12 Protocols To Ease Post-Approval Changes For Analytical Methods

Post-approval change management protocols could go a long way toward smoothing global rollout of analytical method changes, ICH Q12 expert says.

In a Modern Laboratory Two Scientists Conduct Experiments
Industry Urged To Adopt PACMPS For Analytical Method Changes • Source: Shutterstock

The pharmaceutical industry should take advantage of the provision for post-approval change management protocols in the International Council on Harmonization’s Q12 guideline to facilitate analytical procedure changes, a member of the guideline’s implementation working group told a 4 February USP meeting.

The protocols can be used to describe a general approach for changes to analytical procedures across multiple products and testing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Compliance

PBM Investigation, Enforcement Action ‘Critical Priorities’ At FTC, Chair Says

 
• By 

The new FTC chair addressed concerns that staffing cuts will undermine the commission’s commitment to pharmacy benefit manager oversight.

US FDA’s Familiar Drug Pricing To-Do List

 

President Trump’s new Executive Order on drug pricing reprises several policy themes from his first administration, including giving the FDA many tasks intended to increase competition in the marketplace.

Pharma DTC Ad Tax Break Targeted By US HHS, Congress

 

Health and Human Services Secretary Robert F. Kennedy Jr. said a policy that would remove the tax write-off for pharma advertising expenses would be coming in a few weeks.